The National Institutes of Health (NIH) is the largest funder of lupus research in the United States. The NIH's involvement in lupus research has spurred some of the most important medical ...

Pharmaceutical company Johnson & Johnson announced new late-breaking results from its Phase 2 JASMINE study showing that investigational therapy nipocalimab significantly reduced disease activity in ...

This June, we recognize Men’s Health Month 2026 by honoring the strength, challenges and lived experiences of men with lupus.

The Department of Defense (DoD) has announced the availability of nearly $10 million in funding opportunities for high-impact lupus research through the Congressionally Directed Medical Research ...

In a study published in the Annals of the Rheumatic Diseases researchers found that compounds detected in exhaled breath may offer a promising, noninvasive way to better understand and monitor ...

In a new study, researchers found low glomerular filtration rate and chronic histologic damage predicted eGFR loss in people ...

Intrahepatic cholestasis of pregnancy (ICP) is a liver condition that can occur late (after 20 weeks) in pregnancy. A new study found a strong connection between azathioprine (AZA, an ...

The Novartis research study is testing a potential new investigational treatment that is a single infusion of rapcabtagene autoleucel (also called rap-cel) for patients with active, refractory lupus ...